Aviras Remedies Llp - Company Profile

It is a healthcare limited liability partnership based in Pune, Maharashtra, India, established in 2015.
2015 Pune, Maharashtra, India Struck Off
Last Updated:
Access Report
About Aviras Remedies Llp

Aviras Remedies Llp, a struck off limited liability partnership, was established on 10 March 2015 in Pune, Maharashtra, India. Engaging in preventive health services within the healthcare sector, it holds LLPIN: AAD-5138. Registered under ROC Roc Pune. It has total obligation of contribution of ₹0.30 M.

Its leadership includes Vijay Surajmal Changediya (Designated Partner), Sanjay Manohar Shah (Designated Partner), Rahul Ramesh Deshpande (Designated Partner). Past directors included Anil Popatrao Belkar, Rohit Dinanath Karpe. Its latest date of accounts and solvency statement 31 March 2020. It is based at S No 19/1A H No 915 Fl 101 Gondhale Ngr Saswad Rd, Pune, Maharashtra, 411028.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAD-5138

  • Incorporation Date

    10 March 2015

  • Total Obligation of Contribution

    ₹0.30 M

  • ROC Code

    Roc Pune

  • Company Status

    Struck Off

Key Metrics
  • Obligation of Contribution ₹ 0.30 M
  • Company Age 11 Year, 24 Days
  • Last Filing with ROC 31 Mar 2020
Company report

Aviras Remedies Llp

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Aviras Remedies Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Aviras Remedies Llp?
Current Designated Partners
Name Designation Appointment Date Status
Vijay Surajmal Changediya Designated Partner 10 Mar 2015 Current
Sanjay Manohar Shah Designated Partner 10 Mar 2015 Current
Rahul Ramesh Deshpande Designated Partner 10 Mar 2015 Current
Past Designated Partners
Name Designation Cessation Status
Pramod Abcsdd Designated Partner 24 Nov 2018 Past
Pramod Abcsdd Designated Partner 24 Nov 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Aviras Remedies Llp.

Enhance accessibility to Aviras Remedies Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Aviras Remedies Llp revenue growth over time
Aviras Remedies Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Aviras Remedies Llp?

Unlock access to Aviras Remedies Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Aviras Remedies Llp?

Unlock and access historical data on people associated with Aviras Remedies Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Aviras Remedies Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aviras Remedies Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Aviras Remedies Llp
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Aviras Remedies Llp last Annual general meeting of members was held on 31 Mar 2020 as per latest MCA records. was documented.

  • Statement of Assets & Liabilities

    Progress on Aviras Remedies Llp has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Pune. was documented.

  • Director Appointment

    Vijay Surajmal Changediya was appointed as a Designated Partner was appointed as a Designated Partner on 10 Mar 2015 & has been associated with this company since 11 years 24 days . was recorded as a recent event.

  • Director Appointment

    Progress on Sanjay Manohar Shah was appointed as a Designated Partner was appointed as a Designated Partner on 10 Mar 2015 & has been associated with this company since 11 years 24 days . was documented.

  • Director Appointment

    The activity Rahul Ramesh Deshpande was appointed as a Designated Partner was appointed as a Designated Partner on 10 Mar 2015 & has been associated with this company since 11 years 24 days . was completed.

  • LLP Incorporation

    Progress on Aviras Remedies Llp was registered on 10 Mar 2015 with Roc Pune & aged 11 years 24 days as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Aviras Remedies Llp?

The LLPIN of Aviras Remedies Llp is AAD-5138.

Where is Aviras Remedies Llp headquartered?

Aviras Remedies Llp is headquartered at S No 19/1A H No 915 Fl 101 Gondhale Ngr Saswad Rd, Pune, Maharashtra, 411028.

When was Aviras Remedies Llp incorporated?

Aviras Remedies Llp was incorporated on 10 March 2015.

Who are the current directors of Aviras Remedies Llp?

The current directors of Aviras Remedies Llp are

What is the primary industry of Aviras Remedies Llp?

The primary industry of Aviras Remedies Llp is Healthcare.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available